Log In
person
Athenex Inc
ATNXQ
summarize
4 total product lines
calendar_month
Revenue as of 12/31/2021
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Commercial Platform |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
66.99M | 54.76% |
| Global Supply Chain Platform |
Pharmaceuticals and Active Ingredients for Pharmaceuticals
These companies develop and manufacture both finished pharmaceuticals directly to distributors along with Active Pharmaceutical Ingredients (APIs) to other pharmaceutical manufacturers.
|
28.47M | 23.27% |
| Oncology Innovation Platform |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
26.87M | 21.96% |
| Oncology Innovation Platform |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_down |
Commercial Platform
Branded Pharmaceuticals
|
66.99M | 54.76% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||
| keyboard_arrow_down |
Global Supply Chain Platform
Pharmaceuticals and Active Ingredients for Pharmaceuticals
|
28.47M | 23.27% |
| keyboard_arrow_right |
These companies develop and manufacture both finished pharmaceuticals directly to distributors along with Active Pharmaceutical Ingredients (APIs) to other pharmaceutical manufacturers.
|
||
| keyboard_arrow_down |
Oncology Innovation Platform
Pharmaceutical Patent Licensing
|
26.87M | 21.96% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||
| keyboard_arrow_down |
Oncology Innovation Platform
Pre-Revenue Pharmaceuticals
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_right |
help
Why Zero? Explanation of what the heck's going on here.
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||